2024-28433. Determination That Bentyl Preservative Free (Dicyclomine Hydrochloride) Injection, 10 Milligrams/Milliliters, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness  

  • Table 1—Drug Products Not Withdrawn From Sale for Reasons of Safety or Effectiveness

    Application No. Drug name Active ingredient(s) Dosage form/route Strength(s) Applicant
    NDA 008370 BENTYL PRESERVATIVE FREE Dicyclomine Hydrochloride Injectable; Injection 10 Milligrams (mg)/Milliliters (mL) AbbVie.
    NDA 012104 KENALOG Triamcinolone Acetonide Spray; Topical 0.147 mg/Gram (g) Sun Pharmaceutical Industries Limited.
    NDA 017806 THALLOUS CHLORIDE TL 201 Thallous Chloride TL-201 Injectable; Intravenous 1 Millicurie (mCi)/mL; 2 mCi/mL Lantheus.
    NDA 017823 HALOG Halcinonide Solution; Topical 0.10% Sun Pharmaceutical Industries Limited.
    NDA 018849 LIDEX Fluocinonide Solution; Topical 0.05% Alvogen.
    NDA 020551 NIMBEX Cisatracurium Besylate Injectable; Injection Equivalent to (EQ) 2 mg Base/mL AbbVie.
    NDA 020551 NIMBEX PRESERVATIVE FREE Cisatracurium Besylate Injectable; Injection EQ 2 mg Base/mL; EQ 10 mg Base/mL AbbVie.
    ( print page 96655)
    NDA 020837 XOPENEX Levalbuterol Hydrochloride Solution; Inhalation EQ 0.0103% Base; EQ 0.021% Base; EQ 0.042% Base; EQ 0.25% Base Hikma.
    NDA 020857 COMBIVIR Lamivudine; Zidovudine Tablet; Oral 150 mg; 300 mg Viiv Health Care.
    NDA 020977 ZIAGEN Abacavir Sulfate Tablet; Oral EQ 300 mg Base Viiv Health Care.
    NDA 021205 TRIZIVIR Abacavir Sulfate, Lamivudine, Zidovudine Tablet; Oral EQ 300 mg Base, 150 mg, 300 mg Viiv Health Care.
    NDA 021223 ZOMETA Zoledronic Acid Injectable; Intravenous EQ 4 mg Base/100 mL; EQ 4 mg Base/5 mL Novartis.
    NDA 021548 LEXIVA Fosamprenavir Calcium Tablet; Oral EQ 700 mg Base Viiv Health Care.
    NDA 021695 ANTARA (MICRONIZED) Fenofibrate Capsule; Oral 90 mg Lupin.
    NDA 021738 EXTINA Ketoconazole Aerosol, Foam; Topical 2% Mylan.
    NDA 021861 PATANASE Olopatadine Hydrochloride Spray, Metered; Nasal 0.665 mg/Spray Novartis.
    NDA 022128 SELZENTRY Maraviroc Tablet; Oral 25 mg; 75 mg Viiv Health Care.
    NDA 022350 ONGLYZA Saxagliptin Hydrochloride Tablet; Oral EQ 2.5 mg Base; EQ 5 mg Base AstraZeneca AB.
    NDA 050440 KEFLET Cephalexin Tablet; Oral EQ 250 mg Base; EQ 500 mg Base Eli Lilly and Company.
    NDA 050558 ZINACEF Cefuroxime Sodium Injectable; Intramuscular, Intravenous EQ 750 mg Base/Vial; EQ 1.5 g Base/Vial; EQ 7.5 g Base/Vial PAI Pharma.
    NDA 050567 POLYTRIM Polymyxin B Sulfate, Trimethoprim Sulfate Solution/Drops; Ophthalmic 10,000 Units/mL, EQ 1 mg Base/mL Allergan.
    NDA 050588 CEFOTAN Cefotetan Disodium Injectable; Injection EQ 10 g Base/Vial PAI Pharma.
    NDA 050795 DORYX Doxycycline Hyclate Tablet, Delayed Release; Oral EQ 75 mg Base; EQ 150 mg Base Mayne Pharma.
    NDA 200678 KOMBIGLYZE XR Metformin Hydrochloride, Saxagliptin Hydrochloride Tablet, Extended Release; Oral 500 mg, EQ 5 mg Base; 1 g, EQ 5 mg Base; 1 g, EQ 2.5 mg Base AstraZeneca AB.
    NDA 201194 OXYCODONE HYDROCHLORIDE Oxycodone Hydrochloride Solution; Oral 5 mg/5 mL VistaPharm, LLC.
    NDA 204427 KERYDIN Tavaborole Solution; Topical 5% Anacor Pharmaceuticals, Inc.
    NDA 204592 ZORVOLEX Diclofenac Capsule; Oral 35 mg Zyla.
    NDA 204790 TIVICAY Dolutegravir Sodium Tablet; Oral EQ 10 mg Base; EQ 25 mg Base Viiv Health Care.
    NDA 215868 MIDAZOLAM IN 0.8% SODIUM CHLORIDE Midazolam Solution; Intravenous 50 mg/50 mL (1 mg/mL) Exela Pharma.

Document Information

Published:
12/05/2024
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2024-28433
Pages:
96654-96655 (2 pages)
Docket Numbers:
Docket No. FDA-2024-N-5354
PDF File:
2024-28433.pdf